AI Pharma Startup METiS Raises $150 Million. IPO in Sight?
Company has conducted five financing rounds since its establishment in January 2020 Key takeaways: METiS Pharmaceuticals has completed five funding rounds since its establishment in January 2020, including the latest…
Recent Articles
RELATED ARTICLES
-
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK - InSilico seeks IPO boost to get AI drugs over the line
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
-
Everest reaches new heights on growing drug sales
1952.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
